PubMed:19346865 / 1909-2072 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T15","span":{"begin":0,"end":163},"obj":"Sentence"}],"text":"Reversible inferior colliculus lesions could be considered as the characteristic for metronidazole-induced encephalopathy, next to the dentate nucleus involvement."}

{"project":"LitCoin-entities","denotations":[{"id":"5965","span":{"begin":11,"end":38},"obj":"DiseaseOrPhenotypicFeature"},{"id":"5966","span":{"begin":85,"end":98},"obj":"ChemicalEntity"},{"id":"5967","span":{"begin":107,"end":121},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A20","pred":"db_id","subj":"5965","obj":"MESH:D001927"},{"id":"A21","pred":"db_id","subj":"5966","obj":"MESH:D008795"},{"id":"A22","pred":"db_id","subj":"5967","obj":"MESH:D001927"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Reversible inferior colliculus lesions could be considered as the characteristic for metronidazole-induced encephalopathy, next to the dentate nucleus involvement."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T41","span":{"begin":31,"end":38},"obj":"GeneOrGeneProduct"},{"id":"T42","span":{"begin":99,"end":106},"obj":"GeneOrGeneProduct"},{"id":"T43","span":{"begin":143,"end":150},"obj":"GeneOrGeneProduct"}],"text":"Reversible inferior colliculus lesions could be considered as the characteristic for metronidazole-induced encephalopathy, next to the dentate nucleus involvement."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T11","span":{"begin":31,"end":38},"obj":"GeneOrGeneProduct"},{"id":"T12","span":{"begin":143,"end":150},"obj":"GeneOrGeneProduct"}],"text":"Reversible inferior colliculus lesions could be considered as the characteristic for metronidazole-induced encephalopathy, next to the dentate nucleus involvement."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T5","span":{"begin":107,"end":121},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A5","pred":"originalLabel","subj":"T5","obj":"D001927"}],"text":"Reversible inferior colliculus lesions could be considered as the characteristic for metronidazole-induced encephalopathy, next to the dentate nucleus involvement."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T8","span":{"begin":11,"end":38},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T9","span":{"begin":107,"end":121},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A8","pred":"ID:","subj":"T8","obj":"DISEASE"},{"id":"A9","pred":"ID:","subj":"T9","obj":"D001927"}],"text":"Reversible inferior colliculus lesions could be considered as the characteristic for metronidazole-induced encephalopathy, next to the dentate nucleus involvement."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T7","span":{"begin":11,"end":38},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T8","span":{"begin":107,"end":121},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A7","pred":"#label","subj":"T7","obj":"DISEASE"},{"id":"A8","pred":"#label","subj":"T8","obj":"D001927"}],"text":"Reversible inferior colliculus lesions could be considered as the characteristic for metronidazole-induced encephalopathy, next to the dentate nucleus involvement."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T17","span":{"begin":85,"end":98},"obj":"ChemicalEntity"}],"attributes":[{"id":"A17","pred":"ID:","subj":"T17","obj":"D008795"},{"id":"A18","pred":"ID:","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_6909"}],"text":"Reversible inferior colliculus lesions could be considered as the characteristic for metronidazole-induced encephalopathy, next to the dentate nucleus involvement."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T17","span":{"begin":85,"end":98},"obj":"ChemicalEntity"},{"id":"T8","span":{"begin":107,"end":121},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T87488","span":{"begin":11,"end":38},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A18","pred":"ID:","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_6909"},{"id":"A17","pred":"ID:","subj":"T17","obj":"D008795"},{"id":"A36489","pred":"#label","subj":"T8","obj":"D001927"},{"id":"A70057","pred":"#label","subj":"T87488","obj":"DISEASE"}],"text":"Reversible inferior colliculus lesions could be considered as the characteristic for metronidazole-induced encephalopathy, next to the dentate nucleus involvement."}